Table 1.
Parameter | Ovarian cancer | Benign ovarian disease | Healthy control | P value |
---|---|---|---|---|
n | 262 | 258 | 232 | |
Age, y | 43.48 ± 11.45 | 43.19 ± 9.46 | 42.82 ± 12.32 | 0.804 |
WBC, ×109/L | 7.99 ± 3.48* | 6.85 ± 2.29** | 6.09 ± 1.09*** | <0.001 |
Hb, g/L | 105.58 ± 20.46* | 124.50 ± 13.04** | 131.98 ± 7.29*** | <0.001 |
Neutrophils, ×109/L | 5.76 ± 3.39* | 4.21 ± 2.05** | 3.43 ± 0.83*** | <0.001 |
Lymphocytes, ×109/L | 1.54 ± 0.66* | 2.03 ± 0.71** | 2.09 ± 0.45 | <0.001 |
Monocytes, ×109/L | 0.51 ± 0.20* | 0.46 ± 0.16** | 0.40 ± 0.10*** | <0.001 |
CA‐125, U/mL | 92.08 (34.15‐473.45)* | 23.29 (13.10‐37.98)** | 6.34 (4.06‐11.10)*** | <0.001 |
dNLR | 2.29 (1.50‐3.55)* | 1.44 (1.14‐1.88)** | 1.29 (1.06‐1.54)*** | <0.001 |
Data are expressed as mean ± standard deviation or median (interquartile range).
CA‐125, carbohydrate antigen‐125; dNLR, derived neutrophil‐to‐lymphocyte ratio; Hb, hemoglobin; WBC, white blood cell count.
P < 0.05, ovarian cancer group vs benign ovarian disease group.
P < 0.05, ovarian cancer group vs healthy control group.
P < 0.05, benign ovarian disease group vs healthy control group.